Maz Ganat, MD
- Urologic Oncology
- Urology
I am dedicated to providing you the best care possible and helping you choose the best treatment that is right for you. I look forward to meeting you and thank you for choosing me as your doctor.
Related Practices
Specialties, Procedures &
Conditions Treated
Primary Areas of Practice
- Urologic Oncology
- Urology
Other Areas of Practice
- Bloodless Medicine
Procedures
- Adrenalectomy
- Bloodless Medicine & Surgery
- Cystectomy
- Cystoscopy
- Endoscopic Surgery
- Kidney-Sparing Surgery
- Laparoscopic Nephrectomy
- Lithotripsy
- Minimally Invasive Surgery
- MRI/Ultrasound Fusion Prostate Biopsy
- Nephrectomy
- Nephrolithotomy
- Orchiectomy
- Partial Cystectomy
- Partial Nephrectomy
- Percutaneous Transurethral Resection
- Pyeloplasty
- Robotic Nephrectomy
- Robotic Prostatectomy
- Robotic Surgery
- Ureteroscopy (With or Without Biopsy)
Conditions Treated
- Adrenal Cancer
- Adrenal Tumors
- Benign Prostatic Hyperplasia (BPH)
- Bladder Cancer
- Enlarged Prostate
- Genitourinary Fistula
- Hematuria
- Kidney Cancer
- Kidney Stones
- Prostate Cancer
- Prostate Disorders
- Renal Cancer
- Testicular Cancer
- Urologic Cancer
- Urologic Disorders
Locations &
Appointments
Locations
Urology at Englewood - Englewood Health Physician Network
350 Engle Street Suite 6530 Englewood, NJ 07631
Urology at Jersey City - Englewood Health Physician Network
2 Journal Square Plaza 2nd Floor, Medical Suites Jersey City, NJ 07306
Appointments
Book OnlineInsurance
Insurances Accepted
Please contact your insurance company directly prior to receiving services or care to confirm your coverage. Although we have made every effort to ensure this list is accurate, only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.
1199 (SEIU)
- 1199 (SEIU)
Aetna
- Aetna Assure Premier Plus
- Aetna Better Health of New Jersey
- Aetna CCN
- Aetna CoreSource
- Aetna Coventry
- Aetna FIDE-SNP
- Aetna HMO
- Aetna Medicare Managed Care
- Aetna POS
- Aetna PPO
- Aetna Whole Health HMO
- Aetna Whole Health PPO
- Medsolutions
- Meritan Health
AmeriHealth
- AmeriHealth Administrator
- AmeriHealth HMO
- AmeriHealth PPO
- Value Network (Exchange Plan)
APWU
- APWU Health Plan
Cigna
- Cigna HMO
- Cigna Medicare Advantage
- Cigna Open Access Plus
- Cigna PPO
- Cigna Supplemental
- Great-West Healthcare (GWH)
- Health Partners
Clover Health
- Clover Medicare Advantage
EmblemHealth
- EmblemHealth EPO
- EmblemHealth EPO2
- EmblemHealth FEHB
- EmblemHealth FEHBP
- EmblemHealth GHI CBP
- EmblemHealth GHI PPO
- EmblemHealth National
- EmblemHealth PPO1
- EmblemHealth PPO2
- EmblemHealth PPO3
- EmblemHealth Tri-State
- Vytra
Empire BCBS
- Blue Priority
- Direct HMO
- Direct PPO
- Empire BCBS EPO
- Empire BCBS GEPO
- Empire BCBS HealthPlus Gatekeeper (prefix VFG)
- Empire BCBS HealthPlus Gatekeeper (prefix VJD)
- Empire BCBS HMO
- Empire BCBS Indemnity
- Empire BCBS Medicare Advantage
- Empire BCBS Medicare Advantage Plus
- Empire BCBS POS
- Empire BCBS PPO
Empire Plan (NYSHIP)
- Empire Plan (NYSHIP)
Fidelis Care NJ
- Fidelis Care NJ Medicaid Managed Care
First Health
- First Health
GEHA
- GEHA Health Plan
Horizon BCBS
- Federal Employee Program
- Horizon BCBS Braven Health
- Horizon BCBS EPO
- Horizon BCBS HMO
- Horizon BCBS Medicare Managed Care
- Horizon BCBS PPO
- NJ Carpenters Fund
- OMNIA Tier 1
- Traditional
Horizon NJ Health
- Horizon NJ Health Medicaid
- Horizon NJ TotalCare (D-SNP)
Humana
- Humana ChoiceCare Network PPO
- Humana ChoiceCare+ Network PPO
- Humana ChoicePOS
- Humana Gold Choice Network PFFS
- Humana Gold Choice Network PFFS 23
- Humana Gold Plus DE-SNP
- Humana Gold Plus HMO
- Humana Medicare (Employer PPO Plus)
- Humana Medicare PPO
- Humana Medicare PPO 2023
- Humana National Medicare HMO
- Humana National POS - Open Access
- Humana National POS - Open Access Plus
MagnaCare
- Local 825
- MagnaCare PPO
Mail Handlers
- Mail Handlers Benefit Plan (MHBP)
Medicaid
- Medicaid NJ
Medicare
- Medicare NJ
MultiPlan/PHCS
- Beech Street
- MultiPlan Humana
- MultiPlan Worker's Comp
- PHCS
- Pomco
MVP Health Care
- MVP Health Care PPO
NALC
- NALC Health Benefit Plan
Nippon Life Insurance Co of America
- Nippon Life Benefits
Oxford
- Freedom
- Garden State Network
- Liberty
- Metro
- Oxford Medicare
QualCare
- Choice Care
- HIP HMO
- HIP PPO
- HIP PRIME HMO
- HIP PRIME PPO
- Oscar
- QualCare EPO
- QualCare FEHB
- QualCare GHI PPO
- QualCare HMO
- QualCare Humana
- QualCare PPO
- QualCare Worker's Comp
Railroad Medicare
- Railroad Medicare NJ
TRICARE (Humana Military)
- TRICARE (Humana Military)
TRICARE North Region
- CHAMPVA
- DVA
UMR
- UMR
United Healthcare Community and State
- Dual Complete
- UnitedHealthcare Community and State Medicaid (NJ FamilyCare)
- UnitedHealthcare Community and State Medicare
UnitedHealthcare
- AARP
- Commercial and Marketplace
- Compass Benefit (Exchange)
- Medica
- River Valley
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare StudentResources
Wellcare NJ
- Wellcare NJ Ambetter
- Wellcare NJ Medicare Managed Care
Wellpoint
- Wellpoint Medicaid
- Wellpoint Medicare Advantage
About
About Maz Ganat
Dr. Ganat is the chief of urology and program director of Urologic Oncology at Englewood Hospital, specializes in cancers of the prostate, bladder, kidney, testes, and penis and performs both open and robotic surgeries. He obtained his MD from SUNY Downstate College of Medicine and did his internship in surgery and residency in urology at SUNY Downstate Medical Center. Following his residency, Dr. Ganat completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a member of the American Urological Association and the Society of Urologic Oncology. Dr. Ganat's research interests are the immunogenomics of urologic malignancies and precision medicine.
Honors & Awards
2020, 2019: Bergen Magazine Top Doctors
Arnold P. Gold Foundation Humanism Award
Professional Memberships
American Urological Association
Society of Urologic Oncology
Committees and Leadership Positions
Chief, Department of Urology
Education &
Training
Education & Degrees
MD: SUNY Downstate College of Medicine
Residency
SUNY Downstate Medical Center
Fellowship
Memorial Sloan Kettering Cancer Center: Urologic Oncology
Certifications & Distinctions
- Urology (American Board of Urology)
Publications
Publications
Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, andNielsen J. Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cellcarcinoma. Accepted to European Urology Oncology. May 2018
Mendonca S, Sanchez A, Blum K, Ghanaat M, Kashan M, Becerra M, Manley B, Benfante N, Russo P, Coleman J,Crago A, Hakimi AA The Association of Renal Cell Carcinoma with Gastrointestinal Stromal Tumors. The Journal ofSurgical Oncology. Accepted March, 2018 In Press
Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra M, Manley BJ, Casuscelli J,Chiok M, Tikoo S, Akin O, Coleman JA, Russo P, Hakimi AA. Cystic renal cell carcinoma: a report on outcomes ofsurgery and active surveillance in patients retrospectively identified on pretreatment imaging. The Journal of Urology. 2018 Feb 26.
Comparison of Postoperative Ileus Rates Using GIA-80 versus GIA-60 Intestinal Stapler Device after RadicalCystectomy. Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Dalbagni G, HerrHW, Bochner BH, Vickers AJ, and Donat SM. Submitted.
Characterizing Recurrent and Lethal Small Renal Masses in Clear Cell Renal Cell Carcinoma Using Recurrent SomaticMutations.Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI,Sato Y, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA. Urologic Oncology:Seminars and Original Investigations 2017 Nov 11. Elsevier.
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Becerra MF,Reznik E, Redzematovic A, Tennenbaum DM, Ghanaat M, Kashan M, Casuscelli J, Manley BJ, Arcila ME, Carlo MI,Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, and Hsieh JJ. EuropeanUrology Focus. 2017 Oct 20.7. Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma.Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic D, Arcila ME, Tennenbaum DM, GhanaatM, Kashan M, Stief CG, Carlo MI, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, HsiehJJ, Hakimi AA. European Urology Focus. 2017 Sep 23.
Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Winer AG,Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, ColemanJA. In Urologic Oncology: Seminars and Original Investigations 2017 Apr 30 (Vol. 35, No. 4, pp. 151-e9). Elsevier.
Secondary pelvic congestion syndrome: description and radiographic diagnosis. Winer AG, Chakiryan NH, MooneyRP, Verges D, Ghanaat M, Allaei A, Robinson L, Zinn H, Lang EK. The Canadian Journal of Urology. 2014Aug;21(4):7365-8.